Hit-to-lead optimization spans two critical phases of early drug development. In the first, compound libraries are screened to identify active hits. In the second, those hits are refined into lead candidates with defined potency, selectivity, and drug-like properties. High-purity biochemical reagents support the binding assays, enzyme activity tools, and cellular screens that underpin each decision.
Explore our products and services
In lead discovery, biochemical reagents such as enzyme substrates, assay kits, and binding tools enable compound screening against defined biological targets. Well-characterized reagents improve assay signal consistency, reduce run-to-run variability, and support confident identification of hits worthy of further progression.
In lead optimization, biochemical reagents support the SAR studies, selectivity profiling, and early ADMET assessments used to improve compound potency, metabolic stability, and safety margins. Consistent reagent performance across optimization cycles is essential to generate data that meaningfully differentiates structural modifications.
Identify drug candidates via compound libraries.
Refine lead efficacy and safety profiles.
Related categories
High-purity formulations in varied packaging for superior solution stability and pH control.
BioUltra, BioXtra and BioPerformance — certified grades for contamination-sensitive workflows.
Essential derivatives for metabolomics, protein structure, and biosynthesis research.
From cell culture supplements to glycan building blocks – highly pure and research-ready.
Surfactants across all charge types, including REACH-compliant biodegradable alternatives.
Targeted solutions to eliminate contamination, support genetic selection, and aid cell biology.
Proteoglycans, glycoproteins, and glycolipids – a comprehensive selection for every application.
Primary pathway compounds in ready-to-use formats for metabolomics profiling and identification.